Clinical Trials Directory

Trials / Unknown

UnknownNCT03577457

The Interaction Between Oxytocin and Serotonin

The Interaction Between Oxytocin and Serotonin on the Social-reward Brain Networks and Decision Making

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University of Electronic Science and Technology of China · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to identify any interaction between oxytocin and serotonin on neural and behavioral activity related to social reward and decision making by a double-blind, placebo-controlled, between-subject, pharmacological fMRI design

Detailed description

Serotonin and oxytocin have been proved to play an important role in social reward processing and decision making in human. The aim of this study is to determine whether they interact in those essential human behaviors by a double-blind, placebo-controlled, between-subject, pharmacological fMRI design, in which 4 groups of healthy males will be administered with a random combination of nasal oxytocin (24 international units, IU) or placebo and acute tryptophan depletion (ATD, 75.2g) or placebo (a tryptophan-balanced mixture, 78.2g). The social-reward related neural activity and behavior will be assessed by a series of social reward task in and out of fMRI scanner and the decision making will be assessed by reversal learning task, ultimatum game (UG) and loss aversion task. The interaction between serotonin and oxytocin on brain networks will also be tested by resting state.

Conditions

Interventions

TypeNameDescription
DRUGoxytocin nasal sprayintranasal administration of oxytocin (24 IU)
DRUGATD treatmentoral administration of ATD (75.2g) (Acute Tryptophan Depletion)
DRUGintranasal placebo treatment (placebo-control for oxytocin)intranasal administration of placebo nasal spray
DRUGoral placebo treatment (placebo-control for ATD)oral administration of a tryptophan-balanced mixture (78.2g)

Timeline

Start date
2018-02-01
Primary completion
2019-06-20
Completion
2019-07-20
First posted
2018-07-05
Last updated
2018-07-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03577457. Inclusion in this directory is not an endorsement.